Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 3,940 | N/A | N/A |
| Receivables | 1,800 | N/A | N/A |
| Inventories | 1,040 | N/A | N/A |
| Other current assets | 910 | 0 | 0 |
| TOTAL | $7,690 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 16,220 | N/A | N/A |
| Other Non-Current Assets | 60,450 | 0 | 0 |
| TOTAL | $76,670 | $N/A | $N/A |
| Total Assets | $84,380 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 420 | 0 | 0 |
| Accrued Expenses | 3,130 | N/A | N/A |
| Other current liabilities | 9,080 | N/A | N/A |
| TOTAL | $12,640 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 5,060 | N/A | N/A |
| Other Non-Current Liabilities | 860 | 0 | 0 |
| TOTAL | $5,920 | $N/A | $N/A |
| Total Liabilities | $18,580 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 40 | N/A | N/A |
| Retained earnings | 45,740 | N/A | N/A |
| Other shareholders' equity | 4,370 | 0 | 0 |
| TOTAL | $65,790 | $N/A | $N/A |
| Total Liabilities And Equity | $84,370 | $0 | $0 |